Search
for
Sort by
Research 30 of 252
- 1449 PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY
- S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8)
- Gleason grading controversies: what the chemoprevention trials have taught us
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- Two cases of low-prostate-specific antigen localized prostate cancer incidentally detected by computed tomography
- Urological Oncology: Prostate Cancer
- The Role of 5αR Inhibitors in the Early Growth of Pca Cells
- Regarding prostate-specific antigen: let's not shoot the messenger
- Reply
- Every TURP Is not Just BPH
- Pertinence d’une chimioprévention à partir de l’étude PCPT
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Editorial Comment
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Polycystic ovary syndrome: pragmatic management across levels of care
- SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men